Medisca, Inc. is recalling approximately 640,325 grams of Estriol, USP (Micronized), a pharmaceutical ingredient used in hormone replacement therapies. The recall was initiated because the product failed to meet required specifications for impurities and degradation, which means the medication may contain unintended chemical components or have broken down over time. These Estriol products were distributed nationwide in various container sizes including 1 g, 5 g, 25 g, 100 g, 2000 g, and 1 kg. Consumers who may have received compounded medications containing these ingredients should contact their healthcare provider or pharmacist for guidance.
The failure to meet impurity and degradation specifications means the drug may be less effective or contain unexpected chemical byproducts. This could lead to unpredictable patient outcomes or adverse reactions during hormone therapy treatment.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.